Code | 8174C | ||||||||||
MA number | EU/1/18/1280/004 | ||||||||||
Product Form: | plc ifc 4x100 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Sandoz GmbH, Austria | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 48 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(4) similar biological application |
MA issued: | 18.05.2018 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 13.12.2022 |